IGM Financial Inc. ("IGM") (TSX: IGM) today announced details related to Rockefeller Capital Management's ("Rockefeller" or "the firm") transaction, which was announced by Rockefeller in a press ...

After self-funding his startup and defying industry norms, Dr. Herriot Tabuteau has a billion dollar business and a vision ...

Herriot Tabuteau combined his Yale medical degree and two decades in finance to start Axsome Therapeutics. Now the company ...

Trump plans 100% tariff on branded drugs imported to U.S. BioNJ, HINJ warn of risks to patients, jobs & innovation Major pharma firms investing billions in U.S. production sites Industry groups urge ...

On Sept. 29, 1916, it was front page news that a surge in Standard Oil's stock price likely made oil tycoon John D. Rockefeller America's first billionaire. More than a century later, the United ...

In May 2025, the Trump administration issued an executive order titled “Regulatory Relief to Promote Domestic Production of Critical Medicines” directing the Food and Drug Administration (FDA) and the ...

Recursion Pharmaceuticals (NASDAQ: RXRX), a biotech focused on artificial intelligence (AI), became a publicly traded company in 2021 -- a time when AI did not grab nearly as much attention (if any at ...

Investors in ETFs such as SPDR S&P Pharmaceuticals ETF (NYSE: XPH), First Trust NASDAQ Pharmaceuticals ETF (NASDAQ: FTXH), iShares U.S. Pharmaceuticals ETF (NYSE: IHE), and VanEck Pharmaceutical ETF ...

Big Pharma faces uncertainty as the Trump administration pushes MFN drug pricing and 100% tariffs on non-US manufactured patented medicines. Last night's policy announcement around a proposed 100% ...

AstraZeneca said it will offer its asthma and diabetes drugs at an up to 70% discount in the U.S. ahead of a Trump administration deadline for pharmaceutical companies to cut drug prices. The company ...

Trump’s sweeping 100% pharmaceutical tariff starting October 1 triggers massive $270 billion industry investment surge, creating clear stock market winners like Eli Lilly while foreign-dependent ...

President Donald Trump announced Thursday that brand-name or patented pharmaceutical products will be subject to a 100% tariff starting October 1 – unless the drugmaker is building a manufacturing ...